Showing results (2131-2140 of 5,535) with videos related to

Sort By:
Pageof 554
Inflammatory Bowel Diseases|March 17, 2018
Endoscopic Stricturotomy Versus Balloon Dilation in the Treatment of Anastomotic Strictures in Crohn's DiseaseNan Lan, Bo Shen
Inflammatory Bowel Diseases|June 24, 2022
Appendix and Ulcerative Colitis: a Key to Explaining the Pathogenesis and Directing Novel Therapies?Nazanin Arjomand Fard, Heather Armstrong, Troy Perry, et al.
Inflammatory Bowel Diseases|June 24, 2022
MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?Tommaso Innocenti, Elisabetta Bigagli, Erica Nicola Lynch, et al.
Inflammatory Bowel Diseases|June 28, 2022
The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's DiseaseNeeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Inflammatory Bowel Diseases|June 29, 2022
Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled TrialsNabil El Hage Chehade, Sara Ghoneim, Sagar Shah, et al.
Inflammatory Bowel Diseases|June 14, 2022
Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world SettingMillie D Long, Anita Afzali, Monika Fischer, et al.
Inflammatory Bowel Diseases|July 2, 2022
Alterations in the Course of Inflammatory Bowel Disease Following Liver Transplantation: A Systematic Review and Meta-analysisAli Reza Safarpour, Sara Shojaei-Zarghani, Manoosh Mehrabi, et al.
Inflammatory Bowel Diseases|January 13, 2021
IBD Systems Biology Is Here to StayClaudio Fiocchi, Dimitrios Iliopoulos
Inflammatory Bowel Diseases|May 27, 2021
Randomized Controlled Trial Substudy of Cell-specific Mechanisms of Janus Kinase 1 Inhibition With Upadacitinib in the Crohn's Disease Intestinal Mucosa: Analysis From the CELEST StudyDaniel Aguilar, Lluís Revilla, Alba Garrido-Trigo, et al.
Inflammatory Bowel Diseases|February 22, 2020
The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple SwitchesFabio Salvatore Macaluso, Walter Fries, Anna Viola, et al.
Pageof 554